According to global figures from the International Diabetes Federation, there were 537 million adults living with diabetes in 2021, a number predicted to rise to 643 million by 2030 and 783 million by 2045. 1 The fiscal and health burden of diabetes is considerable, and with the predicted growth on an unprecedented scale, it presents a huge opportunity for Pharmacists to provide quality options, advice, and treatment through their ‘value-adding’ lens.
The provision of prescription medication advice, dietary information, and lifestyle tips is a standard part of the Pharmacist’s diabetes armoury, however, the discussion of the role of complementary medicine (CMs) in this space is less clear. The consensus seems to be that CMs require further large-scale evaluations before they can be routinely recommended for widespread use in diabetes, but despite this, several promising studies continue to point to ingredients of growing interest.
×
To continue reading this article, please
Log In or
Sign Up for access.